Evidence map›Paper›PMID 32915636›Full record

ArticleExperimental biology and medicine (Maywood, N.J.)2020

The protective effects of C16 peptide and angiopoietin-1 compound in lipopolysaccharide-induced acute respiratory distress syndrome.

Dingqian Wu, Xiaoxiao Fu, Yuanyuan Zhang, Qiang Li, Ligang Ye, Shu Han, Mao Zhang

Open access · greenAbstract read
In one paragraph

Article in Experimental biology and medicine (Maywood, N.J.), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Dingqian WuThe Emergency Medicine Department; the Second Affiliated Hospital Zhejiang University School of Medicine (SAHZU), Hangzhou 310058, China.
Xiaoxiao FuInstitute of Anatomy and Cell Biology, Medical College, Zhejiang University, Hangzhou 310058, China.
Yuanyuan ZhangInstitute of Anatomy and Cell Biology, Medical College, Zhejiang University, Hangzhou 310058, China.
Qiang LiThe Emergency Medicine Department; the Second Affiliated Hospital Zhejiang University School of Medicine (SAHZU), Hangzhou 310058, China.
Ligang YeThe Emergency Medicine Department; the Second Affiliated Hospital Zhejiang University School of Medicine (SAHZU), Hangzhou 310058, China.
Shu HanInstitute of Anatomy and Cell Biology, Medical College, Zhejiang University, Hangzhou 310058, China.ORCID 0000-0002-7800-2394
Mao ZhangThe Emergency Medicine Department; the Second Affiliated Hospital Zhejiang University School of Medicine (SAHZU), Hangzhou 310058, China.
Second Affiliated Hospital of Zhejiang University · CNZhejiang University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

C16 peptide and angiopoietin-1 (Ang-1) have been found to have anti-inflammatory activity in various inflammation-related diseases. However, their combined role in acute respiratory distress syndrome (ARDS) has not been investigated yet. The objective of this study was to investigate the effects of C16 peptide and Ang-1 in combination with lipopolysaccharide (LPS)-induced inflammatory insult

Indexed as

Amino Acid SequenceAngiopoietin-1AnimalsApoptosisCell LineCell Membrane PermeabilityCell MovementCell ProliferationCytokinesEndothelial CellsEpithelial CellsInflammationLipopolysaccharidesLung InjuryMaleMonocytesAngiopoietin-1C16 peptideCytokinesLipopolysaccharidesPeptide FragmentsPeptidesProtective AgentsAcute respiratory distress syndromeangiopoietin-1C16lipopolysaccharidepulmonary inflammation

Identifiers

PMID32915636
PMCPMC7802387
OpenAlexW3084603859

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.